Stock Taper

PARADIGM BIOCAPITAL ADVISORS LP

Latest 13F filing data - Q2 2026

Holdings

(Top positions)
STOCKTICKERSHARES HELD VALUE
Genmab A/SGMAB13.13M$360.77M
Edgewise Therapeutics, Inc.EWTX10.22M$415.05M
Erasca, Inc.ERAS9.55M$174.96M
Olema Pharmaceuticals, Inc.OLMA8.67M$108.47M
Viridian Therapeutics, Inc.VRDN6.72M$123.52M
Revolution Medicines, Inc.RVMD6.36M$1.19B
Tango Therapeutics, Inc.TNGX6.36M$198.74M
Editas Medicine, Inc.EDIT5.59M$18.1M
Spyre Therapeutics, Inc.SYRE3.84M$340.98M
EyePoint Pharmaceuticals, Inc.EYPT2.89M$41.33M
Jade Biosciences, Inc.JBIO2.86M$63.49M
Tarsus Pharmaceuticals, Inc.TARS2.78M$174.7M
Oruka Therapeutics, Inc.ORKA2.14M$204.09M
Vaxcyte, Inc.PCVX2.13M$123.69M
Tyra Biosciences, Inc.TYRA1.83M$58.41M
Apogee Therapeutics, Inc.APGE1.58M$209.23M
Insmed IncorporatedINSM1.33M$141.38M
Kardigan, Inc.KARD900K$21.46M
MapLight Therapeutics, Inc.MPLT685.85K$24.58M
Alnylam Pharmaceuticals, Inc.ALNY480K$144.49M